• JPM: Sanofi inks $1.1B Kymab buyout to bag midphase eczema drug

    15 days ago - By Fierce Biotech

    JPM: Sanofi inks $1.1B Kymab buyout to bag midphase eczema drug ntaylor
    Mon, 01/11/2021 - 06:49
    Read more ...

     

  • JPM: Bluebird to spin off cancer therapies into new company

    15 days ago - By Fierce Biotech

    JPM: Bluebird to spin off cancer therapies into new company ntaylor
    Mon, 01/11/2021 - 08:21
    Read more ...

     

  • JPM: Regeneron has spoken with the FDA about odronextamab hold, hopes to get patients back soon

    15 days ago - By Fierce Biotech

    JPM: Regeneron has spoken with the FDA about odronextamab hold, hopes to get patients back soon badams
    Mon, 01/11/2021 - 09:28
    Read more ...

     

  • JPM, Day 1: Sanofi grabs a British biotech, Regeneron hopes for FDA hold lift, Bluebird puts its eggs in two baskets, and more

    15 days ago - By Fierce Biotech

    JPM, Day 1: Sanofi grabs a British biotech, Regeneron hopes for FDA hold lift, Bluebird puts its eggs in two baskets, and more badams
    Mon, 01/11/2021 - 11:27
    Read more ...